Literature DB >> 29704162

A Comparison of Motivations for Marijuana Use in HIV-Positive and HIV-Negative Adults.

Sheri L Towe1, Olivia E Horton2, Bianca Martin3, Christina S Meade2,3.   

Abstract

While medicinal marijuana use is common among persons with HIV, it is not known whether persons with HIV are more motivated to use marijuana medically compared to HIV-negative counterparts. This study examined motivations for marijuana use in a sample of 94 HIV+ and HIV- adults. Participants used marijuana 21.27 days in the last 30 days on average. HIV+ participants reported using marijuana for medical reasons more often than HIV- participants, but HIV+ and HIV- participants did not differ in other domains. Problematic marijuana use was associated with motives, regardless of HIV status. Motives were associated with mental and physical health functioning, but there were no interactions between motivations and HIV status. Overall this study found that motivations were similar for HIV+ and HIV- participants. Future research including qualitative work to further understand motivations would benefit the field, as would research examining the effectiveness of marijuana in treating physical symptoms.

Entities:  

Keywords:  Cannabis; HIV/AIDS; Marijuana; Marijuana use disorders; Marijuana use motives

Mesh:

Substances:

Year:  2018        PMID: 29704162      PMCID: PMC6076848          DOI: 10.1007/s10461-018-2123-4

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  30 in total

Review 1.  In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.

Authors:  Rosalie Liccardo Pacula; Mireille Jacobson; Ervant J Maksabedian
Journal:  Addiction       Date:  2016-01-26       Impact factor: 6.526

2.  Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy.

Authors:  M Henderson; F Safa; P Easterbrook; M Hotopf
Journal:  HIV Med       Date:  2005-09       Impact factor: 3.180

3.  Identifying HIV care enrollees at-risk for cannabis use disorder.

Authors:  Bryan Hartzler; Beatriz H Carlini; Howard Newville; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan
Journal:  AIDS Care       Date:  2016-12-23

4.  Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology.

Authors:  Henri Chabrol; Emmanuelle Ducongé; Carine Casas; Charlotte Roura; Kate B Carey
Journal:  Addict Behav       Date:  2005-05       Impact factor: 3.913

5.  Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment.

Authors:  Heidi M Crane; Mary E McCaul; Geetanjali Chander; Heidi Hutton; Robin M Nance; Joseph A C Delaney; Joseph O Merrill; Bryan Lau; Kenneth H Mayer; Michael J Mugavero; Matthew Mimiaga; James H Willig; Greer A Burkholder; Daniel R Drozd; Rob J Fredericksen; Karen Cropsey; Richard D Moore; Jane M Simoni; W Christopher Mathews; Joseph J Eron; Sonia Napravnik; Katerina Christopoulos; Elvin Geng; Michael S Saag; Mari M Kitahata
Journal:  AIDS Behav       Date:  2017-07

6.  Motives for cannabis use in high-risk adolescent users.

Authors:  Courtney L Fox; Sheri L Towe; Robert S Stephens; Denise D Walker; Roger A Roffman
Journal:  Psychol Addict Behav       Date:  2011-09

Review 7.  Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review.

Authors:  Ji-Yeun Park; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2017-05-16       Impact factor: 4.492

8.  Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.

Authors:  Ronald J Ellis; Will Toperoff; Florin Vaida; Geoffrey van den Brande; James Gonzales; Ben Gouaux; Heather Bentley; J Hampton Atkinson
Journal:  Neuropsychopharmacology       Date:  2008-08-06       Impact factor: 7.853

9.  Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort.

Authors:  Matthew J Mimiaga; Sari L Reisner; Chris Grasso; Heidi M Crane; Steven A Safren; Mari M Kitahata; Joseph E Schumacher; W Christopher Mathews; Kenneth H Mayer
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

10.  Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.

Authors:  Margaret Haney; Erik W Gunderson; Judith Rabkin; Carl L Hart; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-15       Impact factor: 3.731

View more
  7 in total

Review 1.  Reciprocal Influences of HIV and Cannabinoids on the Brain and Cognitive Function.

Authors:  Sheri L Towe; Christina S Meade; Christine C Cloak; Ryan P Bell; Julian Baptiste; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2020-05-22       Impact factor: 4.147

2.  Marijuana Use Is Not Associated With Changes in Opioid Prescriptions or Pain Severity Among People Living With HIV and Chronic Pain.

Authors:  Jessica S Merlin; Dustin Long; William C Becker; Edward R Cachay; Katerina A Christopolous; Kasey R Claborn; Heidi M Crane; Eva Jennifer Edelman; Travis I Lovejoy; William Christopher Mathews; Benjamin J Morasco; Sonia Napravnik; Connall OʼCleirigh; Michael S Saag; Joanna L Starrels; Robert Gross; Jane M Liebschutz
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

3.  Cannabis and complementary/alternative self-treatment approaches for symptom management among African American persons living with HIV.

Authors:  Mark K Greenwald; Nora Akcasu; Paige Baal; Angulique Y Outlaw; Jonathan A Cohn; Leslie H Lundahl
Journal:  AIDS Care       Date:  2021-11-07

4.  Medical, therapeutic, and recreational use of cannabis among young men who have sex with men living with HIV.

Authors:  Douglas Bruce; Alida M Bouris; Shannon Bowers; Olivia Blocker; Soo Young Lee; Mary F Glidden; John A Schneider; Daniel H Reirden
Journal:  Addict Res Theory       Date:  2019-06-26

5.  Change in marijuana use and its associated factors among persons living with HIV (PLWH) during the COVID-19 pandemic: Findings from a prospective cohort.

Authors:  Yan Wang; Gladys E Ibañez; Krishna Vaddiparti; Nichole E Stetten; Ruba Sajdeya; Eric C Porges; Ronald A Cohen; Robert L Cook
Journal:  Drug Alcohol Depend       Date:  2021-05-21       Impact factor: 4.852

6.  HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).

Authors:  Tangui Barré; Patrick Mercié; Caroline Lions; Patrick Miailhes; David Zucman; Hugues Aumaître; Laure Esterle; Philippe Sogni; Patrizia Carrieri; Dominique Salmon-Céron; Fabienne Marcellin
Journal:  AIDS Res Ther       Date:  2022-03-15       Impact factor: 2.250

7.  Getting High or Getting By? An Examination of Cannabis Motives, Cannabis Misuse, and Concurrent Psychopathology in a Sample of General Community Adults.

Authors:  Molly L Scarfe; Candice Muir; Karen Rowa; Iris Balodis; James MacKillop
Journal:  Subst Abuse       Date:  2022-08-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.